Extended (Every 12 Weeks or Longer) Dosing Interval With Intravitreal Aflibercept and Ranibizumab in Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of VIEW Trials

To evaluate outcomes and disease characteristics in eyes with neovascular age-related macular degeneration that received intravitreal aflibercept injection (IAI) and ranibizumab every 12 weeks or longer (≥q12 weeks) or less than every 12 weeks (

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of ophthalmology 2019-04, Vol.200, p.161-168
Hauptverfasser:	Khurana, Rahul N., Rahimy, Ehsan, Joseph, W. Anthony, Saroj, Namrata, Gibson, Andrea, Vitti, Robert, Berliner, Alyson J., Chu, Karen, Cheng, YenChieh, Boyer, David S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Angiogenesis Inhibitors - administration & dosage Choroidal Neovascularization - diagnosis Choroidal Neovascularization - drug therapy Choroidal Neovascularization - physiopathology Diabetes Diabetic retinopathy Disease Double-Blind Method Edema Female Fluorescein Angiography Humans Immunotherapy Intravitreal Injections Macular degeneration Male Middle Aged Monoclonal antibodies Ophthalmology Patients Pharmaceuticals Ranibizumab - administration & dosage Receptors, Vascular Endothelial Growth Factor - administration & dosage Recombinant Fusion Proteins - administration & dosage Time Factors Tomography Tomography, Optical Coherence Vascular endothelial growth factor Vascular Endothelial Growth Factor A - antagonists & inhibitors Visual Acuity - physiology Wet Macular Degeneration - diagnosis Wet Macular Degeneration - drug therapy Wet Macular Degeneration - physiopathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To evaluate outcomes and disease characteristics in eyes with neovascular age-related macular degeneration that received intravitreal aflibercept injection (IAI) and ranibizumab every 12 weeks or longer (≥q12 weeks) or less than every 12 weeks (
ISSN:	0002-9394 1879-1891
DOI:	10.1016/j.ajo.2019.01.005